Cystic fibrosis disease. Cystic fibrosis
Conditions
Interventions
Intervention group: The current study is quasi-experimental and has a group of 48 teenagers with cystic fibrosis who meet the inclusion criteria. The content of the training will be approved by 10 pro
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
12 Years to 16 Years
Inclusion criteria
Inclusion criteria: Suffering from cystic fibrosis Not suffering from learning and cognitive diseases Adolescents aged 12-16 years Be busy studying Declare the adolescent's consent and parents' consent to participate in the study Not suffering from other debilitating disorders
Exclusion criteria
Exclusion criteria: In case of lack of satisfaction at any stage of the research, the participants can be excluded from the study n case of not participating in 3 or more sessions in the orientation classes, the participant will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The quality of life score in the PEDSQL children's quality of life questionnaire. Timepoint: Measuring the quality of life score at the beginning of the study and 30 days after the completion of the training classes. Method of measurement: In this study, the quality of life score of adolescents is measured with the valid and reliable "PEDQL children's quality of life" questionnaire.;Academic performance score in the Academic Performance Questionnaire (EPT). Timepoint: Measuring the academic performance score at the beginning of the study and 30 days after the completion of the experimental classes. Method of measurement: In this study, the academic performance score of adolescents is measured with a valid and reliable "Educational Performance (EPT)" questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adolescent treatment adherence score. Timepoint: The treatment compliance score of adolescents is measured at the beginning of the study and 30 days after the completion of the training classes. Method of measurement: The treatment compliance score in this study is measured with the treatment compliance questionnaire of Modanlo et al. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoraya Hossein pour
Tehran University of Medical Sciences
Outcome results
None listed